SCHEMBL30853545

SCHEMBL30853545

c1ccc2nc3ccc4ccccc4c3cc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
GLA P06280 4/20 0.58
HPGD P15428 4/20 0.58
MAPT P10636 4/20 0.58
ACHE P22303 2/20 0.58
RAB9A P51151 4/20 0.57
KDM4E B2RXH2 4/20 0.57
LMNA P02545 3/20 0.57
KMT2A Q03164 3/20 0.57
NPC1 O15118 2/20 0.57
POLB P06746 2/20 0.57
GAA P10253 2/20 0.57
PTBP1 P26599 1/20 0.57
RCE1 Q9Y256 1/20 0.57
HSD17B10 Q99714 4/20 0.56
HIF1A Q16665 2/20 0.56
CYP1B1 Q16678 1/20 0.56
TDP1 Q9NUW8 2/20 0.52
TSHR P16473 2/20 0.52
CYP2A6 P11509 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL297515 1.00 ALDH1A1 (0.58) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL29712310 1.00 ALDH1A1 (0.58) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL17099903 0.98 ALDH1A1 (0.56) ALDH1A1GLAHPGDMAPTACHE
Iodide SCHEMBL10805145 0.98 ALDH1A1 (0.56) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL27526630 0.96 HPRT1 (0.56) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL4299906 0.91 ALDH1A1 (0.70) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL6256852 0.89 ALDH1A1 (0.47) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL604812 0.89 ALDH1A1 (0.60) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL30373734 0.89 ALDH1A1 (0.60) ALDH1A1GLAHPGDMAPTACHE
Phenanthrene SCHEMBL27653554 0.89 ALDH1A1 (0.75) ALDH1A1GLAHPGDMAPTACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146142-A1 WAVELENGTH DOWNCONVERTERS LAMBDA ENERGY LTD (GB) 2026-05-28 US disclosed
EP-4683978-A1 WAVELENGTH DOWNCONVERTERS Lambda Energy Ltd (GB) 2026-01-28 EP disclosed
US-12534558-B2 Polymer terminated with polyaromatic hydrocarbon G-3 CHICKADEE PURCHASER, LLC (US) 2026-01-27 US disclosed
WO-2024194652-A1 WAVELENGTH DOWNCONVERTERS LAMBDA ENERGY LTD (GB) 2024-09-26 WO disclosed
US-20240109996-A1 POLYMER TERMINATED WITH POLYAROMATIC HYDROCARBON MIZUHO BANK, LTD., AS ADMINISTRATIVE AGENT 2024-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534558-B2 Polymer terminated with polyaromatic hydrocarbon POT1, TST, TELO2 ALDH1A1 1635/4885GLA 2534/4885HPGD 1817/4885
US-20260146142-A1 WAVELENGTH DOWNCONVERTERS AAAS, ALAD, MT-ND6 ALDH1A1 570/4885GLA 123/4885HPGD 475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.